Last reviewed · How we verify
Osteosarcoma of bone
Approved treatments
- adriacin · Chipscreen Biosciences, Ltd.
- Hydroxydaunorubicin · University of Colorado, Denver
- Mepact · Takeda France SAS
- Liposomal Doxorubicin · Pfizer
- Doxorubicin Hydrochloride · Pfizer
Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, an enzyme essential for DNA replication and cell division. - Trexall · Generic (originally Lederle Laboratories)
Antifolate that inhibits dihydrofolate reductase (DHFR), blocking DNA synthesis at high doses (oncology) and suppressing inflammation at low doses (autoimmune). - Methotrexat · Biocad
- Hydroxydaunomycin · Weill Medical College of Cornell University
- Adriamycin · Johann Wolfgang Goethe University Hospital
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Osteosarcoma of bone patent landscape — cliff calendar, originator estates, attackable patents
- Osteosarcoma of bone treatment landscape brief
- Osteosarcoma of bone treatment updates RSS
Frequently asked questions about Osteosarcoma of bone
What drugs treat Osteosarcoma of bone?
Tracked treatments include adriacin, Hydroxydaunorubicin, Mepact, Liposomal Doxorubicin, Doxorubicin Hydrochloride, Trexall, Methotrexat, Hydroxydaunomycin.
What is the treatment for Osteosarcoma of bone?
Standard treatment for Osteosarcoma of bone includes adriacin, Hydroxydaunorubicin, Mepact, Liposomal Doxorubicin, Doxorubicin Hydrochloride. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Osteosarcoma of bone patent cliff · Osteosarcoma of bone CI report
- Treatment: adriacin · Chipscreen Biosciences, Ltd.
- Treatment: Hydroxydaunorubicin · University of Colorado, Denver
- Treatment: Mepact · Takeda France SAS
- Treatment: Liposomal Doxorubicin · Pfizer
- Treatment: Doxorubicin Hydrochloride · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing